热门资讯> 正文

Alzament Neuro重新获得纳斯达克合规性

2026-09-16 20:35

Alzamend Neuro(ALZN) 0

Alzamend Neuro (ALZN) received a notification letter from Nasdaq dated September 14, 2026, informing Alzamend that it has regained compliance.
In the compliance notice, Nasdaq stated that Alzamend complies with the equity rule and the matter is now closed.

More on Alzamend Neuro

Seeking Alpha’s Quant Rating on Alzamend Neuro
Historical earnings data for Alzamend Neuro
Financial information for Alzamend Neuro

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。